Quince Therapeutics Presents Preclinical Data at MHSRS 2022 Demonstrating Preclinical Efficacy of Bone-targeting Platform for Traumatic Bone Injury
Quince Therapeutics, Inc. , a biopharmaceutical company advancing innovative precision therapeutics targeting debilitating and rare diseases, today detailed highlights from the company’s... | September 16, 2022
United States Health System Research Symposium Quince Therapeutics Inc Quince Therapeutics Military Health System Research Symposium Effective Pharmaceutical
Source: marketscreener.com